CDH1 and cancer: Previous studies found that the low E‐cadherin expression, a transmembrane glycoprotein, was associated with tumour and metastasis, and E‐cadherin was reduced at the end‐stage of diabetic nephropathy, which may predict possible diabetic nephropathy evolution towards cancer.21